Skip to main content
. 2022 Jul 19;49(13):4727–4735. doi: 10.1007/s00259-022-05910-w

Fig. 2.

Fig. 2

PSA levels over time in patients undergoing radioligand therapy with [177Lu]Lu-PSMA I&T. Patients with sustained decrease of PSA levels are marked in green. Patients with sustained increase of PSA levels are marked in red. Patients with PSA fluctuations (blue) were defined as changes over time after initial increase or decrease and thus, are crossing zero line